Belong.Life Creates Conversational AI SaaS Solution to Support Cancer Clinical Trials

News
Article

Solution designed to accelerate the process of matching patients with eligible clinical trials.

System Artificial intelligence ChatGPT Chat Bot AI , Technology smart robot Ai Chat GPT application software , robot application Chat GPT. Generative AI. Image Credit: Adobe Stock Images/Ruslan Batiuk

Image Credit: Adobe Stock Images/Ruslan Batiuk

Belong.Life has officially launched Tara, a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). According to the company, Tara is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Following the launch of Dave, Tara is Belong’s second AI Health Mentor suite of solutions.

"Since our founding, Belong has provided clinical trial matching services to more than 30,000 patients," said Eliran Malki, CEO, co-founder, Belong.Life, in a company press release. "Tara is a natural extension of our services, helping to optimize clinical trial matching to benefit stakeholders with increased patient recruitment, improved randomization, and reduced costs and logistical challenges. Tara will enable more patients around the world to access clinical trials."

Reference: Belong.Life Launches New Conversational AI SaaS Solution for Cancer Clinical Trial Matching and Recruitment. PR Newswire. September 13, 2023. Accessed September 14, 2023. https://www.prnewswire.com/news-releases/belonglife-launches-new-conversational-ai-saas-solution-for-cancer-clinical-trial-matching-and-recruitment-301926197.html

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.